Literature DB >> 10937883

Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1,-8, and -13 and of TIMP-1.

B E Bachmeier1, A G Nerlich, P Boukamp, R Lichtinghagen, H Tschesche, H Fritz, E Fink.   

Abstract

We investigated cells and conditioned media of the three human keratinocyte cell lines HaCaT (non-tumorigenic), A5 (benign, tumorigenic) and II-4RT (malignant, tumorigenic) with regard to production and secretion of the collagenases-1 to -3 (MMP-1, MMP-8 and MMP-13) and TIMP-1 using semi-nested RT-PCR, Western blots, ELISA, immunocytochemistry and casein zymography. Transcripts of MMP-1, -8, -13 and TIMP-1 were detected in all cell lines by RT-PCR and the corresponding proteins were found in the cytoplasm of all three cell lines by Western blot analysis and/or immunocytochemistry. The conditioned media of the malignant II-4RT cells contain significantly more MMP-1 and MMP-8 than those of HaCaT or A5 as evidenced by immunoblotting and ELISA. In addition to the presence of latent MMP-1, zymography also detected the active form of this enzyme. TIMP-1 was found only in extracts of all three cell lines, predominantly in A5. This study clearly indicates that the epithelial tumor cells synthesize different collagenases and TIMP-1. The malignant clone secretes increased amounts of distinct collagenases compared to the non-tumorigenic cell line, thereby verifying a correlation between biological behaviour and the amount of collagenases. In addition, we provide clear evidence that MMP-8 is not exclusively found in polymorphonuclear granulocytes, but also in keratinocyte cell lines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10937883     DOI: 10.1515/BC.2000.065

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  8 in total

1.  Expression of matrix metalloproteinases in the subretinal fluid correlates with the extent of rhegmatogenous retinal detachment.

Authors:  Chrysanthos Symeonidis; Eudoxia Diza; Eleni Papakonstantinou; Efimia Souliou; George Karakiulakis; Stavros A Dimitrakos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-08-29       Impact factor: 3.117

2.  Gelatinase A (MMP-2), collagenase-2 (MMP-8), and laminin-5 gamma2-chain expression in murine inflammatory bowel disease (ulcerative colitis).

Authors:  Emma Pirilä; Nungavarm S Ramamurthy; Timo Sorsa; Tuula Salo; Jarkko Hietanen; Päivi Maisi
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

3.  Comparative studies on the secretion and activation of MMPs in two reconstructed human skin models using HaCaT- and HaCaT-ras-transfected cell lines.

Authors:  D Nova; C Le Griel; S Holvoet; E Gentilhomme; C Vincent; M J Staquet; D Schmitt; M Serres
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

4.  Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells.

Authors:  Beatrice Bachmeier; Iduna Fichtner; Peter H Killian; Emanuel Kronski; Ulrich Pfeffer; Thomas Efferth
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

5.  Matrix metalloproteinases -8 and -9 and tissue inhibitor of metalloproteinase-1 in burn patients. A prospective observational study.

Authors:  Johanna Hästbacka; Filip Fredén; Maarit Hult; Maria Bergquist; Erika Wilkman; Jyrki Vuola; Timo Sorsa; Taina Tervahartiala; Fredrik Huss
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

6.  The Role of MMP8 in Cancer: A Systematic Review.

Authors:  Krista Juurikka; Georgina S Butler; Tuula Salo; Pia Nyberg; Pirjo Åström
Journal:  Int J Mol Sci       Date:  2019-09-11       Impact factor: 5.923

7.  Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer.

Authors:  J T Korpi; V Kervinen; H Mäklin; A Väänänen; M Lahtinen; E Läärä; A Ristimäki; G Thomas; M Ylipalosaari; P Aström; C Lopez-Otin; T Sorsa; S Kantola; E Pirilä; T Salo
Journal:  Br J Cancer       Date:  2008-02-05       Impact factor: 7.640

Review 8.  The Role of Curcumin in Prevention and Management of Metastatic Disease.

Authors:  Beatrice E Bachmeier; Peter H Killian; Dieter Melchart
Journal:  Int J Mol Sci       Date:  2018-06-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.